HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38
Application
US20260078127A1
Kind: A1
Mar 19, 2026
Inventors
Laurie B. Schenkel, Melissa Marie Vasbinder, Kevin Wayne Kuntz, Nicholas Robert Perl, Jennifer Downing
Abstract
The present invention relates to heterobicyclic amides and related compounds which are inhibitors of CD38 and are useful in the treatment of cancer.
CPC Classifications
C07D 487/04
A61P 35/00
C07D 403/10
C07D 417/10
C07D 471/04
C07D 473/32
C07D 495/04
C07D 513/04
Filing Date
2025-07-15
Application No.
19269389